中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 8
Aug.  2024
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(8): 1661-1665

Value of triglyceride glucose-body mass index in evaluating the severity of hyperlipidemic acute pancreatitis

DOI: 10.12449/JCH240824
  • a.

    Department of Gastroenterology，Tianyou Hospital Affiliated to Wuhan University of Science and Technology，Wuhan 430064，China

  • b.

    Department of Infectious Diseases，Tianyou Hospital Affiliated to Wuhan University of Science and Technology，Wuhan 430064，China

Research funding:

Scientific Research Project of Hubei Provincial Health Commission (WJ2019M257)

More Information
  • Corresponding author: LIU Qun， 1926247724@qq.com （ORCID： 0009-0000-4261-0120）
  • Received Date: 2023-12-06
  • Accepted Date: 2024-02-01
  • Published Date: 2024-08-25
    Abstract
  •   Objective  To investigate the value of triglyceride glucose-body mass index （TyG-BMI） index in predicting the severity of hyperlipidemic acute pancreatitis （HLAP）.  Methods  A retrospective analysis was performed for the clinical data of 185 patients with HLAP who were admitted to Tianyou Hospital Affiliated to Wuhan University of Science and Technology from January 2021 to December 2023， and according to the revised Atlanta classification criteria for acute pancreatitis， they were divided into mild group with 95 patients and moderate or severe group with 90 patients. Clinical features were compared between the two groups to analyze the correlation between TyG-BMI and the severity of HLAP， and the efficacy of TyG-BMI in predicting the severity of HLAP was analyzed. The independent-samples t test or the Mann-Whitney U test was used for comparison of continuous data between two groups， and the chi-square test was used for comparison of categorical data between two groups. Univariate and multivariate Logistic regression analyses were used to investigate the influencing factors for the severity of HLAP. A Spearman correlation analysis was used to investigate the correlation between TyG-BMI and the severity of HLAP， and the receiver operating characteristic （ROC） curve was used to analyze the efficacy of TyG-BMI in predicting the severity of HLAP.  Results  There were significant differences between the mild group and the moderate or severe group in creatinine， blood glucose （GLU）， triglyceride， TyG-BMI， and Bedside Index for Severity in Acute Pancreatitis （BISAP） score （Z=-2.059，-7.217，-7.799，-9.566 and-11.386，all P<0.05）. The multivariate Logistic regression analysis showed that BISAP score （odds ratio ［OR］=4.221， 95% confidence interval ［CI］： 1.421‍ ‍—‍ ‍12.538， P=0.001）， TyG-BMI （OR=1.262， 95%CI： 1.140‍ ‍—‍ ‍1.396， P=0.010）， and GLU （OR=1.316， 95%CI： 1.040‍ ‍—‍ ‍1.666， P=0.022） were independent risk factors for the severity of HLAP and were positively correlated with the severity of HLAP （r=0.839， 0.705， and 0.532， all P<0.05）. In the comparison of the efficacy of these indicators in predicting the severity of HLAP， TyG-BMI had a slightly lower efficacy than BISAP score （Z=-4.368， P<0.001） and a significantly better efficacy than GLU （Z=2.155， P<0.001）， with an area under the ROC curve of 0.891， a sensitivity of 91.10%， and a specificity of 96.80%.  Conclusion  TyG-BMI index has a certain value in predicting the severity of HLAP and can be used in clinical comprehensive assessment of HLAP.

     

    • FullText(HTML)
  • loading
    • References(30)
  • [1]
    LIN XY, ZENG Y, ZHANG ZC, et al. Incidence and clinical characteristics of hypertriglyceridemic acute pancreatitis: A retrospective single-center study[J]. World J Gastroenterol, 2022, 28( 29): 3946- 3959. DOI: 10.3748/wjg.v28.i29.3946.
    [2]
    BÁLINT ER, FŰR G, KISS L, et al. Assessment of the course of acute pancreatitis in the light of aetiology: A systematic review and meta-analysis[J]. Sci Rep, 2020, 10( 1): 17936. DOI: 10.1038/s41598-020-74943-8.
    [3]
    LI M, XING XK, LU ZH, et al. Comparison of scoring systems in predicting severity and prognosis of hypertriglyceridemia-induced acute pancreatitis[J]. Dig Dis Sci, 2020, 65( 4): 1206- 1211. DOI: 10.1007/s10620-019-05827-9.
    [4]
    JIN Q, YANG J, MA HL, et al. Value of different scoring systems in predicting the severity and prognosis of hyperlipidemic acute pancreatitis[J]. J Clin Hepatol, 2022, 38( 11): 2551- 2557. DOI: 10.3969/j.issn.1001-5256.2022.11.022.

    金秋, 杨婧, 马红琳, 等. 不同评分系统预测高脂血症性急性胰腺炎严重程度及预后的价值分析[J]. 临床肝胆病杂志, 2022, 38( 11): 2551- 2557. DOI: 10.3969/j.issn.1001-5256.2022.11.022.
    [5]
    CHO SK, HUH JH, YOO JS, et al. HOMA-estimated insulin resistance as an independent prognostic factor in patients with acute pancreatitis[J]. Sci Rep, 2019, 9( 1): 14894. DOI: 10.1038/s41598-019-51466-5.
    [6]
    CHENG Y, FANG Z, ZHANG XX, et al. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: A retrospective study[J]. Cardiovasc Diabetol, 2023, 22( 1): 75. DOI: 10.1186/s12933-023-01794-8.
    [7]
    SHEMESH E, ZAFRIR B. Hypertriglyceridemia-related pancreatitis in patients with type 2 diabetes: Links and risks[J]. Diabetes Metab Syndr Obes, 2019, 12: 2041- 2052. DOI: 10.2147/DMSO.S188856.
    [8]
    SHAFIQ S, PATIL M, GOWDA V, et al. Hypertriglyceridemia-induced acute pancreatitis-course, outcome, and comparison with non-hypertriglyceridemia associated pancreatitis[J]. Indian J Endocrinol Metab, 2022, 26( 5): 459- 464. DOI: 10.4103/ijem.ijem_206_22.
    [9]
    Chinese Pancreatic Surgery Association, Chinese Society of Surgery, Chinese Medical Association. Guidelines for diagnosis and treatment of acute pancreatitis in China(2021)[J]. Chin J Surg, 2021, 59( 7): 578- 587. DOI: 10.3760/cma.j.cn112139-20210416-00172.

    中华医学会外科学分会胰腺外科学组. 中国急性胰腺炎诊治指南(2021)[J]. 中华外科杂志, 2021, 59( 7): 578- 587. DOI: 10.3760/cma.j.cn112139-20210416-00172.
    [10]
    LIU ZY, TIAN L, SUN XY, et al. Development and validation of a risk prediction score for the severity of acute hypertriglyceridemic pancreatitis in Chinese patients[J]. World J Gastroenterol, 2022, 28( 33): 4846- 4860. DOI: 10.3748/wjg.v28.i33.4846.
    [11]
    XUE Y, XU JH, LI M, et al. Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters[J]. Front Endocrinol(Lausanne), 2022, 13: 951689. DOI: 10.3389/fendo.2022.951689.
    [12]
    BANKS PA, BOLLEN TL, DERVENIS C, et al. Classification of acute pancreatitis: 2012: Revision of the Atlanta classification and definitions by international consensus[J]. Gut, 2013, 62( 1): 102- 111. DOI: 10.1136/gutjnl-2012-302779.
    [13]
    JIN M, BAI XY, CHEN XF, et al. A 16-year trend of etiology in acute pancreatitis: The increasing proportion of hypertriglyceridemia-associated acute pancreatitis and its adverse effect on prognosis[J]. J Clin Lipidol, 2019, 13( 6): 947- 953. DOI: 10.1016/j.jacl.2019.09.005.
    [14]
    POTHOULAKIS I, PARAGOMI P, ARCHIBUGI L, et al. Clinical features of hypertriglyceridemia-induced acute pancreatitis in an international, multicenter, prospective cohort(APPRENTICE consortium)[J]. Pancreatology, 2020, 20( 3): 325- 330. DOI: 10.1016/j.pan.2020.02.010.
    [15]
    ER LK, WU S, CHOU HH, et al. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals[J]. PLoS One, 2016, 11( 3): e0149731. DOI: 10.1371/journal.pone.0149731.
    [16]
    SZATMARY P, GRAMMATIKOPOULOS T, CAI WH, et al. Acute pancreatitis: Diagnosis and treatment[J]. Drugs, 2022, 82( 12): 1251- 1276. DOI: 10.1007/s40265-022-01766-4.
    [17]
    HEGYI P, SZAKÁCS Z, SAHIN-TÓTH M. Lipotoxicity and cytokine storm in severe acute pancreatitis and COVID-19[J]. Gastroenterology, 2020, 159( 3): 824- 827. DOI: 10.1053/j.gastro.2020.07.014.
    [18]
    SIMHA V. Management of hypertriglyceridemia[J]. BMJ, 2020, 371: m3109. DOI: 10.1136/bmj.m3109.
    [19]
    CHEN MM, YANG NL, GE WL, et al. Investigation on the current situation of eating habits of patients with hyperlipidemic acute pancreatitis and analysis of its influencing factors[J]. Clin J Med Off, 2023, 51( 9): 978- 981. DOI: 10.16680/j.1671-3826.2023.09.25.

    陈明媚, 杨宁琍, 葛万里, 等. 高脂血症性急性胰腺炎患者饮食习惯现状调查及影响因素分析[J]. 临床军医杂志, 2023, 51( 9): 978- 981. DOI: 10.16680/j.1671-3826.2023.09.25.
    [20]
    KISS L, FŰR G, PISIPATI S, et al. Mechanisms linking hypertriglyceridemia to acute pancreatitis[J]. Acta Physiol(Oxf), 2023, 237( 3): e13916. DOI: 10.1111/apha.13916.
    [21]
    YANG AL, MCNABB-BALTAR J. Hypertriglyceridemia and acute pancreatitis[J]. Pancreatology, 2020, 20( 5): 795- 800. DOI: 10.1016/j.pan.2020.06.005.
    [22]
    POTHOULAKIS I, PARAGOMI P, TUFT M, et al. Association of serum triglyceride levels with severity in acute pancreatitis: Results from an international, multicenter cohort study[J]. Digestion, 2021, 102( 5): 809- 813. DOI: 10.1159/000512682.
    [23]
    ZHANG RW, DENG LH, JIN T, et al. Hypertriglyceridaemia-associated acute pancreatitis: Diagnosis and impact on severity[J]. HPB(Oxford), 2019, 21( 9): 1240- 1249. DOI: 10.1016/j.hpb.2019.01.015.
    [24]
    ONYANGO AN. Cellular stresses and stress responses in the pathogenesis of insulin resistance[J]. Oxid Med Cell Longev, 2018, 2018: 4321714. DOI: 10.1155/2018/4321714.
    [25]
    NAGY A, JUHÁSZ MF, GÖRBE A, et al. Glucose levels show independent and dose-dependent association with worsening acute pancreatitis outcomes: Post-hoc analysis of a prospective, international cohort of 2250 acute pancreatitis cases[J]. Pancreatology, 2021, 21( 7): 1237- 1246. DOI: 10.1016/j.pan.2021.06.003.
    [26]
    AUNE D, MAHAMAT-SALEH Y, NORAT T, et al. High body mass index and central adiposity is associated with increased risk of acute pancreatitis: A meta-analysis[J]. Dig Dis Sci, 2021, 66( 4): 1249- 1267. DOI: 10.1007/s10620-020-06275-6.
    [27]
    YE C, LIU L, MA X, et al. Obesity aggravates acute pancreatitis via damaging intestinal mucosal barrier and changing microbiota composition in rats[J]. Sci Rep, 2019, 9( 1): 69. DOI: 10.1038/s41598-018-36266-7.
    [28]
    HUANG Q, WU Z, ZHANG YY, et al. Obesity exacerbates acute gastrointestinal injury and intestinal barrier dysfunction in early-stage acute pancreatitis[J]. Turk J Gastroenterol, 2023, 34( 4): 421- 426. DOI: 10.5152/tjg.2023.22145.
    [29]
    ZHAN CX, PENG Y, YE HJ, et al. Triglyceride glucose-body mass index and cardiovascular mortality in patients undergoing peritoneal dialysis: A retrospective cohort study[J]. Lipids Health Dis, 2023, 22( 1): 143. DOI: 10.1186/s12944-023-01892-2.
    [30]
    SONG B, ZHAO XF, YAO TC, et al. Triglyceride glucose-body mass index and risk of incident type 2 diabetes mellitus in Japanese people with normal glycemic level: A population-based longitudinal cohort study[J]. Front Endocrinol(Lausanne), 2022, 13: 907973. DOI: 10.3389/fendo.2022.907973.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(4)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (211) PDF downloads(23) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return